StockData
BioNTech SE logo

BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$84.86−0.40 (-0.47%)

Close on Nov 17, 2026Market cap $21.32BP/E –Yield –

BioNTech gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 77.6%, against 80.3% the year before. The highest annual figure on record is 89.3% in fiscal 2018.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202577.6%−2.7
FY2024Dec 31, 202480.3%−4.0
FY2023Dec 31, 202384.3%+1.6
FY2022Dec 31, 202282.7%−2.0
FY2021Dec 31, 202184.7%−3.0
FY2020Dec 31, 202087.7%+3.7
FY2019Dec 31, 201984.0%−5.3
FY2018Dec 31, 201889.3%+4.4
FY2017Dec 31, 201784.9%–

More BioNTech figures

See a number that looks wrong?